Sana Biotechnology Inc. (SANA)
3.36
-0.27 (-7.44%)
At close: Jan 15, 2025, 9:50 AM
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost of Revenue | 30.86M | 27.73M | 17.91M | 10.17M | 3.92M | 1K |
| Gross Profit | -30.86M | -27.73M | -17.91M | -10.17M | -3.92M | -1K |
| Operating Income | -326.90M | -272.56M | -356.91M | -286.15M | -141.15M | -8.22M |
| Interest Income | 9.94M | 3.76M | 676.00K | 747.00K | 2.86M | n/a |
| Pretax Income | -283.25M | -269.48M | -355.93M | -285.31M | -138.32M | -13.25M |
| Net Income | -283.25M | -266.39M | -344.18M | -278.64M | -130.78M | -13.25M |
| Selling & General & Admin | 73.30M | 71.56M | 50.41M | 28.27M | 21.78M | 4.21M |
| Research & Development | 221.64M | 201.00M | 306.50M | 257.88M | 119.38M | 4.01M |
| Other Expenses | n/a | -674.00K | 305.00K | 97.00K | -29.00K | n/a |
| Operating Expenses | 294.94M | 272.56M | 356.91M | 286.15M | 141.15M | 8.22M |
| Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | -4.21M |
| Cost & Expenses | 325.81M | 272.56M | 356.91M | 286.15M | 141.15M | 8.22M |
| Income Tax | n/a | -3.09M | -11.75M | -6.67M | -7.55M | n/a |
| Shares Outstanding (Basic) | 194.54M | 188.34M | 166.43M | 187.51M | 187.34M | 187.34M |
| Shares Outstanding (Diluted) | 194.54M | 188.34M | 166.43M | 187.51M | 187.34M | 187.34M |
| EPS (Basic) | -1.46 | -1.41 | -2.07 | -1.49 | -0.7 | -0.07 |
| EPS (Diluted) | -1.46 | -1.41 | -2.07 | -1.49 | -0.7 | -0.07 |
| EBITDA | -252.39M | -256.94M | -356.91M | -287.03M | -138.90M | -13.25M |
| Depreciation & Amortization | 30.86M | 27.73M | 17.91M | 10.17M | 3.92M | 1K |